FindTrial
Sign In

Thrombopoietin Receptor Agonist

DRUG2 trials

Sponsors

The First Affiliated Hospital of Soochow University, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Conditions

Autoimmune Hemolytic AnemiaAutoimmune NeutropeniaChronic Idiopathic NeutropeniaCold Agglutinin DiseaseImmune ThrombocytopeniaMyelodysplastic SyndromesPoor Graft Function

Phase 3

Decitabine for Poor Graft Function Post Allo-HSCT
Not yet recruitingNCT05907499
The First Affiliated Hospital of Soochow UniversityPoor Graft Function
Start: 2023-07-01End: 2026-11-01Target: 76Updated: 2023-06-18

Unknown Phase

Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune Neutropenia
RecruitingNCT05931718
Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoAutoimmune Hemolytic Anemia, Autoimmune Neutropenia, Chronic Idiopathic Neutropenia +3
Start: 2019-06-01End: 2035-06-30Target: 200Updated: 2024-10-15

Related Papers

Restoring hematopoiesis after low dose decitabine of poor graft function post allogenic hematopoietic stem cell transplantation
Blood2025-11-03
Recombinant erythropoietin in autoimmune hemolytic anemia with inadequate bone marrow response: a prospective analysis
Blood Advances2023-11-2920 citations
Transfusions in autoimmune hemolytic anemias: Frequency and clinical significance of alloimmunization
Journal of Internal Medicine2023-11-2710 citations